We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation

By HospiMedica International staff writers
Posted on 16 Oct 2026

When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. More...

This can lead to patient-prosthesis mismatch, causing the heart to continue pumping against increased resistance and potentially worsening clinical outcomes while limiting future valve-in-valve options. To address this challenge, researchers have developed a surgical technique that enlarges the aortic root while preserving the established workflow of valve replacement.

The Alfred Kocher technique was developed at the Department of Cardiac and Thoracic Aortic Surgery at the Medical University of Vienna and University Hospital Vienna. The approach is designed for patients undergoing surgical aortic valve replacement when annular size limits prosthetic valve selection. It has been published with initial clinical findings in JTCVS Techniques.

The operation starts like a conventional aortic valve replacement. After measuring the aortic annulus, surgeons determine whether enlargement is needed. If required, the aortic root is expanded using a T-shaped incision and reconstructed with a specially shaped patch. The coronary arteries remain unaffected, and the natural geometry of the aortic root is largely preserved, allowing implantation of prosthetic valves at least two sizes larger.

The technique forms part of a broader effort to standardize surgical aortic valve replacement. The workflow includes measuring the native aortic annulus with a universally applicable measuring head, selecting the appropriate valve, and enlarging the aortic root when necessary. Several invention disclosures related to the approach have been submitted for patent in collaboration with the Department of Technology Transfer at the Medical University of Vienna.

“The key advantage of our technique is that we initially proceed as with conventional aortic valve replacement and only need to decide whether an enlargement is necessary after taking the measurements. With a comparatively simple additional surgical step, we can implant significantly larger prosthetic valves without affecting the coronary arteries. It is particularly important that the technique can be performed not only via conventional access but also using minimally invasive and even endoscopic methods,” said Alfred Kocher, head of the Heart Valve Team at the Department of Cardiac and Thoracic Aortic Surgery at the Medical University of Vienna and University Hospital Vienna.

“In aortic valve surgery, we must now take into account not only the immediate operation but also our patients' entire subsequent treatment pathway. A sufficiently large prosthetic valve is a key prerequisite for this. The new technique expands our ability to create optimal conditions for long-term care right from the first procedure,” said Daniel Zimpfer, head of the Department of Cardiac and Thoracic Aortic Surgery.

Related Links
Medical University of Vienna


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Glucose Meter
StatStrip®
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: The tool analyzes 3D time-of-flight MR angiography to measure brain vessel length, radius, volume, branching, tortuosity, and other structural features. (Photo courtesy of University of Rochester Medical Center)

MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease

Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.